Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on the Pharmacokinetics of Tersolisib in Healthy Participants
NCT07662798Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tersolisib (4 arms), sponsored by Eli Lilly and Company. Primary endpoints: Maximum Concentration and Area Under the Concentration Versus Time Curve. Started Jul 2026; status: completed.
02
Drugs
tersolisib
Beyond the preview
Go deeper on NCT07662798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07662798.